Overview

Comparison of the Effect of Subcutaneous Progesterone and Vaginal Progesterone for Luteal Phase Support

Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
0
Participant gender:
Female
Summary
The invesigators aimed to seperate the patients,which is going to be applied IUI, to two different groups as prospective randomized controlled ;assess the efficacy of the two different way pressurised progesterone by appling intravaginal progesterone to the first group; subcutaneous to the second group.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Bezmialem Vakif University
Treatments:
Progesterone
Criteria
Inclusion Criteria:

- Absence of follicles larger than 10 mm on basal ultrasound

- Endometrial thickness less than 5 mm

- Patients with FSH<10 IU/ml, E2<60-80 pg/ml in the blood hormone test performed on the
third day of the cycle and patients with antral follicle count above 7 on ultrasound

- Total motile sperm count greater than 10 million/ml

- 18-40 years old female, 18-50 years old male

- Anovulation, patients diagnosed with unexplained mild male factor infertility

- Female partners, who's BMI<25 kg/m²

- Being voluntarily

Exclusion Criteria:

- Other infertility reasons

- The patients who doesn't meet the criterias

- Refusing to attend to the research